Organization
Shenzhen Salubris Pharmaceuticals
4 clinical trials
Clinical trial
A Multi-center, Randomized, Double-blind, Placebo Parallel Controlled Phase III Clinical Trial for the Efficacy and Safety of Fugliglitinate Benzoate Tablets in Patients With Type 2 Diabetes Who Cannot be Effectively Controlled by MetforminStatus: Completed, Estimated PCD: 2022-05-24
Clinical trial
A Multi-center, Randomized, Double-blind, Placebo/Positive Parallel Phase III Clinical Trial to Evaluate the Efficacy and Safety of SAL067 in Type 2 Diabetes Patients Who Cannot Effectively Control Blood Glucose Through Diet and ExerciseStatus: Completed, Estimated PCD: 2022-03-25
Clinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study of SAL-0951 Tablets in the Treatment of Renal Anemia in Non-dialysis Chronic Kidney DiseaseStatus: Completed, Estimated PCD: 2021-10-08
Clinical trial
Efficacy and Safety of Allisartan Isoproxil/Amlodipine Tablets in Patients With Essential Hypertension Uncontrolled With Amlodipine or Allisartan Isoproxil: A Phase III, Multicenter, Randomized, Double-blind, Parallel-controlled, 52-week Clinical StudyStatus: Completed, Estimated PCD: 2022-08-16